Nuvilex, Inc. Could Become Significant Player in the Oncology Arena With Successful Phase III Trials
May 22, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 22, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is a diamond in the rough in the truest sense. Currently shares of the Silver Spring, Maryland, biotechnology firm can...
Nuvilex, Inc. and Celgene, Corp. Can Both Replace Eli Lilly's Cancer Drug Gemzar
May 20, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 20, 2013) - The race is on, and patients with advanced stage, inoperable pancreatic cancer will be the recipients of the winner's treatment. Two biotechnology...
Nuvilex, Inc.'s Dr. Gerald Crabtree Discusses Upcoming Phase III Cancer Trials, Fast Track and Orphan Drug Status
May 13, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 13, 2013) - Nuvilex, Inc. (OTCQB: NVLX) COO Dr. Gerald Crabtree is no stranger to late stage clinical trials or dealing with blockbuster therapies for cancer...
Cutting Edge Information Sees Burst of Innovation From Pharma and Biotech, Studies Regulatory Atmosphere
November 03, 2009 12:13 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - November 3, 2009) - The pharmaceutical and
biotechnology industries are on the verge of both a burst of innovative new
products and a change in mindset from...